# Medication Review, Inc.: Form D filings

Medication Review, Inc., a pharmaceuticals company in Spokane, WA, filed 2 Form D notices with the SEC between 2010 and 2012. The latest, on March 22, 2012, reports $12,000 sold of a $2.5 million offering to 1 investor.

Find out what Medication Review, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Medication%20Review%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Medication%20Review%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmedication-review-inc-1497310)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Medication%20Review%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Medication%20Review%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmedication-review-inc-1497310)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Washington](https://specstream.ai/data/form-d/state/washington): 1,095 rows, by operating companies, filed since November 1, 2024, $54.75, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/washington
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 104 S. FREYA, Suite 217 White Flag Building, Spokane, WA, 99202
- Phone: (509) 343-5200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Washington
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506, Securities Act section 4(6)
- SEC identifier (CIK): 1497310

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 22, 2012 | New notice | $2,500,000 | $12,000 | $2,488,000 | 1 | Mar 19, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497310/000149731012000001/0001497310-12-000001-index.htm) |
| Sep 21, 2010 | New notice | $400,000 | $195,000 | $205,000 | 6 | Sep 15, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1497310/000149731010000001/0001497310-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| K. Douglas Crafton | Executive Officer, Director |  |
| Tom R. Jensen, MPA | Director |  |
| Christopher R Terriff, RPh | Executive Officer |  |
| James F Karel, MS | Director |  |
| Mary R Giannini | Director |  |
| Michael R. Anderegg | Executive Officer |  |
| Kyle R Downey, PharmD | Executive Officer |  |
| Linda F Garrelts-MacLean, BPharm, RPh | Director |  |

## Other pharmaceuticals companies in Washington that filed recently

- [Aptevo Therapeutics Inc.](https://specstream.ai/data/form-d/company/aptevo-therapeutics-inc-1671584) $3.5 million · Aug 26, 2026

[Every Form D from the week of Mar 19, 2012](https://specstream.ai/data/form-d/week/2012-03-19) · [All recent filings in Washington](https://specstream.ai/data/form-d/state/washington) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Medication Review, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).